Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis

Methods in Molecular Biology

Volumn 494, Issue , 2008, Pages 223-246

  Cudic, Predrag ^a   Stawikowski, Maciej ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Depsides; Depsipeptides; Fmoc solid phase synthesis; Isosteres; Oligourea; Peptidomimetics; Peptidosulfonamides; Peptoids; Phosphonopeptides; Pseudopeptides

Indexed keywords

EID: 84934437653     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-419-3_13     Document Type: Article

References (85)

1. Marx, V. (2005) Watching peptide drugs grow up. C&EN, 83, 17-24.
2. Adessi, C., and Soto, C. (2002) Converting a peptide into drug: strategies to improve stability and bioavailability. Curr. Med. Chem. 9, 963-978.
3. Sawyer, T. K. (2000) Peptidomimetic and nonpeptide drug discovery: chemical nature and biological targets, in Peptide and Protein Drug Analysis (R. E. Reid, ed.), Marcel Dekker, New York, pp. 81-115.
4. Davies, J. S. (2003) The cyclization of peptides and depsipeptides. J. Pept. Sci. 9, 471-501.
5. Lambert, J. N., Mitchell, J. P., and Roberts, K. D. (2001) The synthesis of cyclic peptides. J. Chem. Soc, Perkin Trans. 1, 471-484.
6. Li, P., and Roller, P. P. (2002) Cyclization strategies in peptide derived drug design. Curr. Top. Med. Chem. 2, 325-341.
7. Blackburn, C., and Kates, S. A. (1997) Solid-phase synthesis of cyclic homodetic peptides. Methods Enzymol . 289, 175-198.
8. Hruby, V. J., and Bonner, G. G. (1994) Design of novel synthetic peptides including cyclic conformationally and topographically constrained analogs. Methods. Mol. Biol. 35, 201-240.
9. Kates, S. A., Sole, N. A., Albericio, F., and Barany, G. (1994) Solid-phase synthesis of cyclic peptides, in Peptides: Design, Synthesis, and Biological Activity, Birkhauser, Boston, pp. 39-59.
10. Ahn, J. M., Boyle, N. A., MacDonald, M. T., and Janda, K. D. (2002), Peptidomimetics and peptide backbone modification. Mini Rev. Med. Chem., 2, 463-473.
11. Goodman, M., Felix, A., Moroder, L., and Toniolo, C., eds. (2004) Synthesis of Peptides and Peptidomimetics, Thieme, Stuttgart.
12. Spatola, A. F. (1983) Peptide backbone modifications in chemistry and biochemistry of amino acids, in Peptides and Proteins (Weinstein, B., ed.), Marcel Dekker, New York, pp. 267-357.
13. Radkiewicz, J., McAllister M. A., Goldstein, E., and Houk, K. N. (1998) A theoretical investigation of phosphonoamidates and sulfonoamides as protease transition state isosteres. J. Org. Chem. 63, 1419-1428.
14. Moree, W. J., Schouten, A., Kroon, J., and Liskamp, R. M. J. (1995) Peptides containing the sulfonamide transition-state isostere: synthesis and structure of N-acetyl-taryl-L-prolinemethylamide. Int. J. Pept. Prot. Res. 45, 501-507.
15. Paik, S., and White, E. H. (1996) α-Aminosulfonopeptides as possible functional analogs of penicillin; evidence for their extreme instability. Tetrahedron 52, 503-5318.
16. Liskamp, R. M. J., and Kruijtzer A. W. (2004) Peptide transformastion leading to peptide-peptidosulfonamide hybrids and oligo peptidosulfonamides. Mol. Divers., 8, 79-87.
17. De Jong, R., Rijkers, D. T. S., and Liskamp, R. M. J. (2002) Automated solid-phase synthesis and structural investigation of β-peptidosulfonamides and β-peptidosulfonamide/β-peptide hybrids: β-peptidosulfonamide and β-peptide foldamers are two of a different kind. Helv. Chim. Acta 85, 4230-4243.
18. De Bont, D. B. A., Dijkstra, G. D. H., Den Hartog, J. A. J., and Liskamp, R. M. J. (1996) Solid-phase synthesis of peptidosulfonamide containing peptides derived from Leu-enkephalin. Bioorg. Med. Chem. Lett. 6, 3035-3040.
19. De Bont, D. B. A., Sliedregt, K. M., Hofmeyer, L. J. F., and Liskamp, R. M. J. (1999) Increased stability of peptidosulfonamide peptidomimetics towards protease catalyzed degradation. Bioorg. Med. Chem. 7, 1043-1047.
20. Moree, W. J., Vand der Marel, G. A., and Liskamp R. M. J. (1995) Synthesis of peptidosulfinamides and peptidosulfonamides: peptidomimetics containing the sulfinamide or sulfonamide transition-state isostere. J. Org. Chem. 60, 5157-5169.
21. Humljan, J., Kotnik, M., Boniface, A., et al. (2006) A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial peptidoglycan biosynthesis enzymed MurD and MurE. Tetrahedron 62, 10980-10899.
22. Humljan, J., and Gobec, S. (2005) Synthesis of N-phthalimido β-aminoethanesulfonyl chlorides: the use of thionyl chloride for a simple and efficient synthesis of new peptidosulfonamide building blocks. Tetrahedron Lett. 46, 4069-4072.
23. Brouwer, A. J., Monnee, M. C. F., and Liskamp R. M. J. (2000) An efficient synthesis of N-protected β-aminoethanesulfonyl chlorides: versatile building blocks for the synthesis of oligopeptidosulfonamides. Synthesis, 1579-1584.
24. Monnee, M. C. F., Marijne, M. F., Brouwer, A. J., and Liskamp R. M. J. (2000) A practical solid phase synthesis of oligopeptidesulfonamide foldamers. Tetrahedron Lett. 41, 7991-7995.
25. Van Ameijde, J., and Liskamp R. M. J. (2000) Peptidomimetic building blocks for the synthesis of sulfonamide peptoids. Tetrahedron Lett. 41, 1103-1106.
26. Gennari, C., Gude, M., Potenza, D., and Piarulli, U. (1998) Hydrogen-bonding donor/acceptor scales in β-sulfonamidopeptides. Chem. Eur. J. 4, 1924-1931.
27. De Bont, D. B. A., Moree, W. J., and Liskamp, R. M. J. (1996) Molecular diversity of peptidomimetics: approaches to the solid-phase synthesis of peptidosulfonamides. Bioorg. Med. Chem. 4, 667-672.
28. Rodriguez, M., Llinares, M., Doulut, S., Heitz, A., and Martinez, J. (1991) A facile synthesis of chiral N-protected β-amino alcohols. Tetrahedron Lett. 32, 923-926.
29. Krchnak, V., Vagner, J., and Lebl, M. (1988) Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Int. J. Pept. Protein Res. 32, 415-416.
30. th ed. (Goodman, M., Felix, A., Moroder, L., and Toniolo, C., eds.), Thieme, Stuttgart, pp. 492-528.
31. Palacios, F., Alonso, C., and de los Santos, J. (2004) β-Phosphono- and phosphinopeptides derived from β-amino-phosphonic and phosphinic acids. Curr. Org. Chem. 8, 1481-1496.
32. Bird, J., De Mello, R. C., Harper, G. P., et al. (1994) Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase. J. Med. Chem. 37, 158-169.
33. De Lombeart, S., Erion, M. D., Tan, J., et al. (1994) N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors. J. Med. Chem. 37, 1498-1511.
34. Barlett, P. A., Hanson, J. E., and Giannousis, P. P. (1990) Potent inhibition of pepsin and penicillopepsin by phosphorus-containing peptide analogs. J. Org. Chem. 55, 6268-6274.
35. Campbell, D. A., and Bermak, J. C. (1994) Solid-phase synthesis of peptidylphosphonates. J. Am. Chem. Soc., 116, 6039-6040.
36. Campbell, D. A., and Bermak, J. C. (1994) Phosphonate ester synthesis using a modified Mitsunobu condensation. J. Org. Chem. 59, 658-660.
37. Campbell, D. A. (1992) The synthesis of phosphonate esters, an extension of the Mitsunobu reaction. J. Org. Chem. 57, 6331-6335.
38. Champagne, J.-M., Coste, J., and Jouin, P. (1995) Solid phase synthesis of phosphonopeptides. Tetrahedron Lett. 36, 2079-2082.
39. Champagne, J.-M., Coste, J., and Jouin, P. (1993) Synthesis of mixed phosphonate diester analogues of dipeptides using BOP or PyBOP reagents. Tetrahedron Lett. 34, 6743-6744.
40. Seebach, D., Charczuk, R., Berber, C., Renaud, P., Bener, H., and Schneider, H. (1989) Electrochemical decarboxylation of L-threonine and oligopeptide derivatives with formation of N-acyl-N,O-acetals: preparation of oligopeptides with amide or phosphonate C-terminus. Helv. Chim. Acta 72, 401-425.
41. Nicolau, K. C., Winssinger, N., Pastor, J., and DeRoose, F. (1997) A general and highly efficient solid phase synthesis of oligosaccharides. Total synthesis of a heptasaccharide phytoalexin elicitor (HPE). J. Am. Chem. Soc. 119, 449-450.
42. Gademann K., and Seebach D. (2001) Synthesis of cyclo-β-tripeptides and their biological in vitro evaluation as antiproliferatives against the growth of human cancer cell lines. Helv. Chim. Acta 84, 2924-2937.
43. Tamilarasu, N., Hoq, I., and Rana, T.M. (2001) Targeting RNA with peptidomimetic oligomers in human cells. Bioorg. Med. Chem. Lett. 11, 505-507.
44. Appella, D.H., Christianson, L.A., Karle, I.L., Powell, D.R., and Gellman, S. H. (1996) β-Peptide foldamers: robust helix formation in a new family of β-amino acid oligomers. J. Am. Chem. Soc. 118, 13071-13072.
45. Wang, X., Espinosa, J. F., and Gellman, S. H. (2000) 12-Helix formation in aqueous solution with short β-peptides containing pyrrolidine-based residues. J. Am. Chem. Soc. 122, 4821-4822.
46. Hanessian, S., Luo, R., Schaum, S., and Michcnik, S. (1998) Design of decondary dtructures in unnatural peptides: stable helical γ-tetra-, hexa-, and octapeptides and consequences of α-substitution. J. Am. Chem. Soc. 120, 8569-8570.
47. Hanessian, S., Luo, X., and Schaum, R. (1999) Synthesis and folding preferences of γ-amino acid oligopeptides: stereochemical control in the formation of a reverse turn and a helix. Tetrahedron Lett. 40, 4925-4929.
48. Seebach, D., Ciceri, P., Overhand, M., et al. (1996) Probing the helical secondary structure of short-chain β-peptides. Helv. Chim. Acta 79, 2043-2066.
49. Seebach, D. Sifferlen, T., Mathieu, P. A., et al. (2000) CD spectra in methanol of β-oligopeptides consisting of β-amino acids with functionalized side chains, with alternating configuration, and with geminal backbone substituents - fingerprints of new secondary structures. Helv. Chim. Acta 83, 2849-2864.
50. Skurski, P., and Simons. J. (2001) An excess electron bound to urea. I. Canonical and zwitterionic tautomers. J. Chem. Phys. 115, 8373-8380.
51. Burgess, K., Ibarzo, J., Linthicum, D. S., et al. (1997) Solid phase synthesis of oligoureas, J. Am. Chem. Soc. 119, 1556-1564.
52. Kim, J.-M., Bi, Y., Paikoff, S. J., and Scultz, P. G. (1996) The solid phase synthesis of oligoureas. Tetrahedron Lett. 37, 5305-5308.
53. Boeijen, A., van Ameijde, J., and Liskamp, R. M. (2001) Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy. J. Org. Chem. 66, 8454-8462.
54. Boeijen, A., and Liskamp, R. M. (1999) Solid-phase synthesis of oligourea peptidomimetics. Eur. J. Org. Chem. 2127-2135.
55. Alsina, J., Scott, W. L., and O'Donell, M. J., (2005) Solid-phase synthesis of α-substituted proline hydantoins and analogs. Tetrahedron Lett. 46, 3131-3135.
56. Nefzi, A., Giulianotti, M., Truong, L., Rattan, S., Ostresh, J. M., and Houghten, R. A., (2002) Solid-phase synthesis of linear ureas tethered to hydantoins and thiohydantoins. J. Comb. Chem. 4, 175-178.
57. Shemyakin, M. M., Shchukina, L. A., Vinogradova, E. I., Ravidel, G. A., and Ovchinnikov, Y. A. (1966) Mutual replaceability of amide and ester groups in biologically active peptide and depsipeptides. Experimentia 22, 535-536.
58. Bramson, H. N., Thomas, N. E., and Kaiser, E. T. (1985) The use of N-methylated peptides and depsipeptides to probe the binding of heptapeptide substrates to cAMPdependent protein kinase. J. Biol. Chem. 260, 15452-15457.
59. Arad, O., and Goodman, M., (1990) Depsipeptide analogues of elastin repeating sequences: synthesis. Biopolymers 29, 1633-1649.
60. Coombs, G. S., Rao, M. S., Olson, A. J., Dawson, P. E., and Madison, E. L. (1999) Revisiting catalysis by chymotrypsin family serine proteases using peptide substrates and inhibitors with unnatural main chains. J. Biol. Chem. 274, 24074-24079.
61. Davidson, B. S. (1993) Ascidians: producers of amino acid-derived metabolites. Chem. Rev. 93, 1771-1791.
62. Fusetani, N., and Matsunaga, S. (1993) Bioactive sponge peptides. Chem. Rev. 93, 1793-1806.
63. Woo, A. J., Strohl, W. R., and Priestley, N. D. (1999) Nonactin biosynthesis: the product of nonS catalyzes the formation of the furan ring of nonactic acid. Antimicrob. Agents Chemother. 43, 1662-1668.
64. Stawikowski, M., and Cudic, P. (2006) Depsipeptide synthesis, in Peptide Characterization and Application Protocols (Fields, G. B., ed.), Humana Press, Totowa, NJ, pp. 321-339.
65. Kuisle, O., Lolo, M., Quinoa, E., and Riguera, R. (1999) Solid phase synthesis of depsides and depsipeptides. Tetrahedron 55, 14807-14812.
66. Kuisle, O., Quinoa, E., and Riguera, R., (1999) A general methodology for automated solid-phase synthesis of depsides and depsipeptides. Preparation of a valinomycin analogue. J. Org Chem. 64, 8063-8075.
67. Marder, O., and Albericio, F. (2003) Industrial application of coupling reagents in peptides. Chim. Oggi 6, 35-40.
68. Berry J. D., Digiovanna V. C., Metrick S. S., and Murugan R. (2001) Catalysis by 4-dialkylaminopyridines. Arkivoc i, 201-226.
69. Stawikowski, M., and Cudic, P. (2006)A novel strategy for the solid-phase synthesis of cyclic lipodepsipeptides. Tetrahedron Lett. 47, 8587-8590.
70. Park, B.-D., and Lee, Y.-S. (2000) The effect of PEG groups on swelling properties of PEG-grafted-polystyrene resins in various solvents. React. Funct. Polymers 44, 41-46.
71. Hudson, D. (1988) Methodological implications of simultaneous solid-phase peptide synthesis. 1. Comparison of different coupling procedures. J. Org. Chem. 53, 617-624.
72. Podlech J. (2001) Carbodiimides, in Synthesis of Peptides and Peptidomimetics, 4th ed. (Goodman, M., Felix, A., Moroder, L., and Toniolo, C., eds.), Thieme, Stuttgart, pp. 517-533.
73. Patch, J. A., Kirshenbaum, K., Seurynck, S., Zuckermann, R., and Barron, A. E. (2004) Versatile oligo (N-substituted) glycines: the many roles of peptoids in drug discovery, in Pseudo-Peptides in Drug Development (Neilsen, P. E., ed.), Wiley-VCH, Weinheim, pp. 1-31.
74. Kwon, Y. U., and Kodadek, T. (2007) Quantitative evaluation of the relative cell permeability of peptoids and peptides. J. Am. Chem. Soc. 129, 1508-1509.
75. Schröder, T., Schmitz, K., Niemeier, N., et al. (2007) Solid-phase synthesis, bioconjugation, and toxicology of novel cationic oligopeptoids for cellular drug delivery. Bioconjugate Chem. ASAP Article; DOI: 10.1021/bc0602073.
76. Miller, S. M., Simmon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1995) Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers. Drug Dev. Res. 35, 20-32.
77. Stawikowski, M., Stawikowska, R., Jaskiewicz, A., Zablotna, E., and Rolka, K. (2005) Examples of peptide-peptoid hybrid serine protease inhibitors based on the trypsin inhibitor SFTI-1 with complete protease resistance at the P1-P1′ reactive site. Chembiochem. 6, 1057-1061.
78. Simon, R. J., Kania, R. S., Zuckermann, R. N., et al. (1992) Peptoids: a modular approach to drug discovery. Proc. Natl. Acad. Sci. USA 89, 9367-9371.
79. Kruijtzer, J. A. W., Hofmeyer, L. J. F., Heerma, W., Versluis, C., and Liskamp, R. M., J. (1998) Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro)peptoids of Leu-enkephalin and substance P. Chem. Eur. J. 4, 1570-1580.
80. Uno, T., Beausoleil, E., Goldsmith, R. A., Levine, B.H., and Zuckermann, R. N. (1999) New submonomers for poly N-substituted glycines (peptoids). Tetrahedron Lett. 40, 1475-1478.
81. Zuckermann, R. N., Kerr, J.M., Kent, S. B. H., and Moos, W. H. (1992) Efficient method for the preparation of peptoids oligo(N-substituted glycines) by submonomer solid-phase synthesis. J. Am. Chem. Soc. 114, 10646-10647.
82. Ostergaard, S., and Holm, A. (1997) Peptomers: a versatile approach for the preparation of diverse combinatorial peptidomimetic bead libraries. Mol. Diver. 3, 17-27.
83. Boeijen, A., and Liskamp, R. M. J. (1998) Sequencing of peptoid peptidomimetics by Edman degradation. Tetrahedron Lett. 39, 3589-3592.
84. Greene, W. T., and Wuts, G. M. P. (1999) Protective Groups in Organic Synthesis, 3rd ed., John Wiley & Sons, Inc., New York, p. 198.
85. Bernatowicz, M. S., Daniels, S. B., and Koster, H. (1989) A comparison of acid labile linkage agents for the synthesis of peptide C-terminal amides. Tetrahedron Lett. 30, 4645-4648.